Who owns Amicus Therapeutics?

Key details on Amicus Therapeutics (Ticker: FOLD)

Who owns Amicus Therapeutics?

Is FOLD a good stock to own? Find out who bought Amicus Therapeutics, who sold Amicus Therapeutics (FOLD) stock, and who holds a large position in Amicus Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 14.79M $206.98M Sept. 30, 2015
Perceptive Advisors 14.44M $175.58M Sept. 30, 2015
Redmile 8.33M $116.58M Sept. 30, 2015
Vanguard 6.23M $60.41M Dec. 31, 2015
Sectoral Asset Management 6.11M $85.50M Sept. 30, 2015
T. Rowe Price Associates 5.89M $82.37M Sept. 30, 2015
NEA Management Company 5.65M $47.03M Dec. 31, 2014
BlackRock Fund Advisors 5.36M $52.00M Dec. 31, 2015
CITADEL ADVISORS 4.28M $59.88M Sept. 30, 2015
Janus Capital Management 4.25M $59.48M Sept. 30, 2015
venBio Select Advisor 4.25M $59.46M Sept. 30, 2015
Jennison Associates 4.12M $40.00M Dec. 31, 2015
Millennium Management 3.73M $52.25M Sept. 30, 2015
RS INVESTMENT MANAGEMENT 3.49M $33.84M Dec. 31, 2015
STATE STREET CORPORATION 3.39M $47.39M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 2.97M $28.85M Dec. 31, 2015
FRAZIER MANAGEMENT 2.92M $28.31M Dec. 31, 2015
HealthCor Management 2.28M $6.11M Dec. 31, 2012
ALLIANCEBERNSTEIN 1.98M $27.70M Sept. 30, 2015
Palo Alto Investors 1.97M $27.62M Sept. 30, 2015
Emerald Mutual Fund Advisers, Trust 1.97M $19.07M Dec. 31, 2015
Franklin Resources 1.81M $25.57M June 30, 2015
Emerald Advisers 1.73M $16.83M Dec. 31, 2015
Bridger Management 1.71M $9.01M March 31, 2012
Dr. Jeffrey R. Jay, M.D 1.64M $5.64M Dec. 31, 2011
Balyasny Asset Management 1.44M $15.63M March 31, 2015
Wellington Management Company 1.42M $3.31M June 30, 2013
Longwood Capital Partners 1.40M $19.65M Sept. 30, 2015
D. E. Shaw & Co 1.39M $19.51M Sept. 30, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.37M $4.58M June 30, 2014
Candriam Luxembourg S.C.A. 1.35M $14.69M March 31, 2015
NORTHERN TRUST 1.26M $17.68M Sept. 30, 2015
GOLDMAN SACHS 1.26M $17.82M June 30, 2015